-
Mashup Score: 0Overview of SYNC-T Technology from Syncromune in Prostate Cancer Treatment - Charles Link, MD - 10 day(s) ago
Dive into the SYNC-T technology by Syncromune® Inc. and its groundbreaking approach to hormone-refractory prostate cancer. Learn how it stimulates an immune response within the tumor microenvironment and adjacent lymph nodes.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 12Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies - Elias Jabbour, MD - 10 day(s) ago
Introduction to Emerging Therapies in ALL Management … Dr. Elias Jabbour shared recent developments in the treatment of acute lymphoblastic leukemia (ALL) during a recent medical conference. His presentation focused on the evolving landscape of ALL therapy, particularly emphasizing the growing importance of targeted therapies including bispecific antibodies, antibody-drug conjugates (ADCs), and tyrosine kinase inhibitors
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Revolutionizing Pancreatic Cancer Detection: The Groundbreaking Role of Liquid Biopsies - Ajay Goel, PhD [AACR 2024] - 18 day(s) ago
Uncover a revolutionary approach to pancreatic cancer detection. Delve into the study’s methodology and learn how microRNAs are used in liquid biopsies for unparalleled accuracy.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Targeting SCD1 in KRAS Mutant Non-Small Cell Lung Cancer: A Novel Therapeutic Strategy - 20 day(s) ago
Uncover the impact of SCD1 in NSCLC with concurrent KRAS, STK11, and KEAP1 mutations. Learn about the potential of SCD1 as a novel therapeutic target for overcoming treatment resistance in lung cancer.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
Learn about the remarkable response rate and complete response rate of Lenvosiltamab in multiple myeloma patients. Explore this potential paradigm shift in treatment.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 14
Find out how combining traditional chemotherapies with Lurbinectedin can improve outcomes in small cell lung cancer. Discover the therapeutic potential of this innovative treatment.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6MOASC 2024 Oncology Summit Archives - 1 month(s) ago
… The Medical Oncology Association of Southern California (MOASC) 2024 Summit has once again set a benchmark in oncology, providing … … At the MOASC Annual Oncology Summit & Research Symposium, Dr. Karen Reckamp, MD, MS, a leading figure in medical … … Melanoma treatment has significantly evolved due to extensive research and the introduction of novel therapeutic options. Dr. Justin T. … … The field of oncology is witnessing a paradigm shift in the treatment of lymphomas, fueled by the emergence of … …
Source: oncologytube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6MOASC 2024 Oncology Summit Archives - 1 month(s) ago
… The Medical Oncology Association of Southern California (MOASC) 2024 Summit has once again set a benchmark in oncology, providing … … At the MOASC Annual Oncology Summit & Research Symposium, Dr. Karen Reckamp, MD, MS, a leading figure in medical … … Melanoma treatment has significantly evolved due to extensive research and the introduction of novel therapeutic options. Dr. Justin T. … … The field of oncology is witnessing a paradigm shift in the treatment of lymphomas, fueled by the emergence of … …
Source: oncologytube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Spotlight on Myeloma 2024: Innovations and Insights from ASH - 2 month(s) ago
Stay up-to-date with the latest advancements in multiple myeloma treatment. Discover the benefits of integrating CD38 monoclonal antibodies and quadruplet regimens.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Take a closer look at MEGA-CRISPR, a new tool in cancer therapy. Learn how this RNA-targeting technology is set to redefine precision medicine and revolutionize genetic research.
Source: oncologytube.comCategories: General Medicine News, Onc News and JournalsTweet
Overview of SYNC-T Technology from @syncromune in Prostate Cancer Treatment – Charles Link, MD Watch Video: https://t.co/RN0GIBrD0h #AACR24 #EndCancer #ProstateCancer https://t.co/GVu17hSzBB